Table 1 Baseline characteristics
From: GDF15 affects venous thrombosis by promoting EndMT through smad2/p-smad2 pathway
Characteristics |  | VTE group(n = 17) | Control group(n = 17) |
|---|---|---|---|
Age |  | 62.1 ± 8.8 | 60.1 ± 5.4 |
Sex | Â | Â | Â |
| Â | male | 8 (47.1%) | 10 (58.8%) |
| Â | female | 9 (52.9%) | 7 (41.2%) |
Past history | Â | Â | Â |
| Â | Hypertension | 5 (29.4%) | 3 (17.6%) |
| Â | Diabetes | 5 (29.4%) | 2 (11.8%) |
| Â | Hyperlipidemia | 4 (23.5%) | 4 (23.5%) |
Thrombus type | PTE | 12 | Â |
|  | PTE + DVT | 5 |  |